If the Obama administration’s $215 million Precision Medicine Initiative is to succeed, policymakers must modernize the regulatory system to better enable big data analytics to be used in genomic research.

That’s the conclusion of a new white paper on genomics released by the Center for Data Innovation and Health IT Now Coalition, which provides recommendations to policymakers. As the National Institutes of Health develops an implementation plan for the initiative, which is due to President Obama in September, the paper stresses the need for active public-private partnerships in development of precision medicine.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access